News Glybera, the most expensive drug in the world, to be withdra... Glybera, the gene therapy which is the most expensive drug in the world, is to be with
News Samsung Biologics agrees $1.81bn takeover of PolyPeptide Samsung Biologics has agreed to buy PolyPeptide, a Swiss CDMO, in what is thought to be South Korea's largest biopharma acquisition to date.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
